scholarly article | Q13442814 |
P356 | DOI | 10.1038/CGT.2011.87 |
P698 | PubMed publication ID | 22281757 |
P2093 | author name string | C-H Lee | |
N-T Chiu | |||
L-H Shen | |||
A-L Shiau | |||
B-F Lee | |||
C-C Hsia | |||
P2860 | cites work | Molecular imaging of hypoxia with radiolabelled agents | Q37378239 |
Provision of positive and negative selections in retroviral vectors containing the cytosine deaminase gene | Q39441859 | ||
Accumulation of Tc-99m HL91 in tumor hypoxia: in vitro cell culture and in vivo tumor model | Q39906522 | ||
Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine | Q40126431 | ||
Hypoxia-induced cytosine deaminase gene expression for cancer therapy | Q40191401 | ||
Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91. | Q40711399 | ||
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report | Q44374111 | ||
Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice | Q45857922 | ||
99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma | Q49065318 | ||
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O | Q53540375 | ||
Targeting gene expression to hypoxic tumor cells | Q57377984 | ||
Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy | Q68327742 | ||
Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo | Q77654025 | ||
Technetium-99m HL91 uptake as a tumour hypoxia marker: relationship to tumour blood flow | Q77953098 | ||
P433 | issue | 4 | |
P921 | main subject | hypoxia | Q105688 |
gene therapy | Q213901 | ||
P304 | page(s) | 255-262 | |
P577 | publication date | 2012-01-27 | |
P1433 | published in | Cancer Gene Therapy | Q15763088 |
P1476 | title | Hypoxia imaging predicts success of hypoxia-induced cytosine deaminase/5-fluorocytosine gene therapy in a murine lung tumor model | |
P478 | volume | 19 |
Q28481716 | Yeasts acquire resistance secondary to antifungal drug treatment by adaptive mutagenesis | cites work | P2860 |
Search more.